Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:54 PM
Ignite Modification Date:
2025-12-24 @ 6:54 PM
NCT ID:
NCT01874457
Eligibility Criteria:
Inclusion Criteria:
* Children of both sexes;
* Age between 12 months to 23 months and 29 days;
* Child in good health, with no significant past medical history;
* Have completed blood sampling before vaccination;
* Have not been vaccinated with MMR.
* Agreement by parents/tutors with the child's participation in the study and signing of the Informed Consent Form (ICF);
* Parents/Tutors provide name, address, telephone number and other information for the contact if necessary;
* Parents/Tutors able to understand the risks of the experiment, although minimal;
* Parents/Tutors able to understand and sign the informed consent form.
* Availability of return for collecting post-vaccination samples.
Exclusion criteria:
* Children with a history of measles, rubella and / or mumps.
* Having received MMR vaccine previously, as documented in vaccination card.
* Having received a transfusion of blood or blood products, including immunoglobulins, within last 12 months.
* Skin lesions at sites of venipuncture.
* Child subject to abnormal bleeding after injections.
* Use within 6 months of corticosteroids (excluding topical or aerosol) and immunosuppressants.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
12 Months
Maximum Age:
24 Months
Study:
NCT01874457
Study Brief:
Protocol Section:
NCT01874457